Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Amino acids and derivatives, a new treatment of chronic heart failure?

Carubelli V, Castrini AI, Lazzarini V, Gheorghiade M, Metra M, Lombardi C.

Heart Fail Rev. 2015 Jan;20(1):39-51. doi: 10.1007/s10741-014-9436-9. Review.

PMID:
24925377
2.

Suppression of circulating free fatty acids with acipimox in chronic heart failure patients changes whole body metabolism but does not affect cardiac function.

Halbirk M, Nørrelund H, Møller N, Schmitz O, Gøtzsche L, Nielsen R, Nielsen-Kudsk JE, Nielsen SS, Nielsen TT, Eiskjær H, Bøtker HE, Wiggers H.

Am J Physiol Heart Circ Physiol. 2010 Oct;299(4):H1220-5. doi: 10.1152/ajpheart.00475.2010. Epub 2010 Aug 13.

3.

The role of amino acids in the modulation of cardiac metabolism during ischemia and heart failure.

Marazzi G, Rosanio S, Caminiti G, Dioguardi FS, Mercuro G.

Curr Pharm Des. 2008;14(25):2592-604. Review.

PMID:
18991676
4.

Oral amino acid supplements improve exercise capacities in elderly patients with chronic heart failure.

Aquilani R, Viglio S, Iadarola P, Opasich C, Testa A, Dioguardi FS, Pasini E.

Am J Cardiol. 2008 Jun 2;101(11A):104E-110E. doi: 10.1016/j.amjcard.2008.03.008.

PMID:
18514618
5.

Effect of taurine supplementation on exercise capacity of patients with heart failure.

Beyranvand MR, Khalafi MK, Roshan VD, Choobineh S, Parsa SA, Piranfar MA.

J Cardiol. 2011 May;57(3):333-7. doi: 10.1016/j.jjcc.2011.01.007. Epub 2011 Feb 19.

6.

The cellular and physiologic effects of beta blockers in heart failure.

Sabbah HN.

Clin Cardiol. 1999 Oct;22 Suppl 5:V16-20. Review.

7.

Biventricular pacing (cardiac resynchronization therapy): an evidence-based analysis.

Health Quality Ontario.

Ont Health Technol Assess Ser. 2005;5(13):1-60. Epub 2005 Sep 1.

8.

Effects of exercise on left ventricular systolic and diastolic properties in patients with heart failure and a preserved ejection fraction versus heart failure and a reduced ejection fraction.

Zile MR, Kjellstrom B, Bennett T, Cho Y, Baicu CF, Aaron MF, Abraham WT, Bourge RC, Kueffer FJ.

Circ Heart Fail. 2013 May;6(3):508-16. doi: 10.1161/CIRCHEARTFAILURE.112.000216. Epub 2013 Mar 20.

9.

The effect of multiple micronutrient supplementation on left ventricular ejection fraction in patients with chronic stable heart failure: a randomized, placebo-controlled trial.

McKeag NA, McKinley MC, Harbinson MT, Noad RL, Dixon LH, McGinty A, Neville CE, Woodside JV, McKeown PP.

JACC Heart Fail. 2014 Jun;2(3):308-17. doi: 10.1016/j.jchf.2013.12.008. Erratum in: JACC Heart Fail. 2014 Oct;2(5):549.

PMID:
24952700
10.

A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.

McKenna C, Burch J, Suekarran S, Walker S, Bakhai A, Witte K, Harden M, Wright K, Woolacott N, Lorgelly P, Fenwick L, Palmer S.

Health Technol Assess. 2010 May;14(24):1-162. doi: 10.3310/hta14240. Review.

11.

Cardiovascular and metabolic effects of 48-h glucagon-like peptide-1 infusion in compensated chronic patients with heart failure.

Halbirk M, Nørrelund H, Møller N, Holst JJ, Schmitz O, Nielsen R, Nielsen-Kudsk JE, Nielsen SS, Nielsen TT, Eiskjaer H, Bøtker HE, Wiggers H.

Am J Physiol Heart Circ Physiol. 2010 Mar;298(3):H1096-102. doi: 10.1152/ajpheart.00930.2009. Epub 2010 Jan 15.

12.

Should we start prescribing omega-3 polyunsaturated fatty acids in chronic heart failure?

Jarreau TK, Lee JH, Lavie CJ, Ventura HO.

Curr Heart Fail Rep. 2012 Mar;9(1):8-13. doi: 10.1007/s11897-011-0073-5. Review.

PMID:
22045435
13.

Nutritional assessment in heart failure patients.

Lee JH, Jarreau T, Prasad A, Lavie C, O'Keefe J, Ventura H.

Congest Heart Fail. 2011 Jul-Aug;17(4):199-203. doi: 10.1111/j.1751-7133.2011.00239.x. Epub 2011 Jul 21. Review.

14.

Cardiac resynchronization therapy for the management of chronic heart failure.

Abraham WT.

Am Heart Hosp J. 2003 Winter;1(1):55-61. Review.

PMID:
15785177
15.

Relationship of left heart size and left ventricular mass with exercise capacity in chronic heart failure.

Shen YQ, Wang LM, Che L, Song HM, Zhang QP.

Chin Med J (Engl). 2011 Aug;124(16):2485-9.

16.

Effects of supplementation with polyunsaturated fatty acids in patients with heart failure.

Nodari S, Triggiani M, Manerba A, Milesi G, Dei Cas L.

Intern Emerg Med. 2011 Oct;6 Suppl 1:37-44. doi: 10.1007/s11739-011-0671-y. Review.

PMID:
22009611
17.

Impairment in walking capacity and myocardial function in the elderly: is there a role for nonpharmacologic therapy with nutritional amino acid supplements?

Scognamiglio R, Testa A, Aquilani R, Dioguardi FS, Pasini E.

Am J Cardiol. 2008 Jun 2;101(11A):78E-81E. doi: 10.1016/j.amjcard.2008.03.005.

PMID:
18514631
18.

Testosterone supplementation in heart failure: a meta-analysis.

Toma M, McAlister FA, Coglianese EE, Vidi V, Vasaiwala S, Bakal JA, Armstrong PW, Ezekowitz JA.

Circ Heart Fail. 2012 May 1;5(3):315-21. doi: 10.1161/CIRCHEARTFAILURE.111.965632. Epub 2012 Apr 17. Review.

19.

Relationship of age and exercise performance in patients with heart failure: the HF-ACTION study.

Forman DE, Clare R, Kitzman DW, Ellis SJ, Fleg JL, Chiara T, Fletcher G, Kraus WE; HF-ACTION Investigators.

Am Heart J. 2009 Oct;158(4 Suppl):S6-S15. doi: 10.1016/j.ahj.2009.07.018.

20.

Cardiopulmonary exercise testing characteristics in heart failure patients with and without concomitant chronic obstructive pulmonary disease.

Guazzi M, Myers J, Vicenzi M, Bensimhon D, Chase P, Pinkstaff S, Arena R.

Am Heart J. 2010 Nov;160(5):900-5. doi: 10.1016/j.ahj.2010.07.014.

PMID:
21095278
Items per page

Supplemental Content

Write to the Help Desk